Clinical Trials Browser

Phase 2 × carfilzomib × Genitourinary × Clear all

NCT01775930 2020-03-04

Carfilzomib in Refractory Renal Cell Carcinoma (RCC)

Phase 2 Completed

10 enrolled 13 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02047253 2018-12-19

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

Phase 2 Completed

28 enrolled 12 charts

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms